BIS icon

ProShares UltraShort NASDAQ Biotechnology

10 hedge funds and large institutions have $6.05M invested in ProShares UltraShort NASDAQ Biotechnology in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 2 closing their positions.

Holders
10
Holders Change
-1
Holders Change %
-9.09%
% of All Funds
0.23%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
1
Increased
5
Reduced
3
Closed
2
Calls
$247K
Puts
Net Calls
+$247K
Net Calls Change
-$1.15M
Name Market Value Shares Shares
Change
Shares
Change %
HVC
1
Healthcare Value Capital
New Jersey
$2.92M 150,000 +75,000 +100%
WP
2
WealthSource Partners
California
$1.11M 56,900 +900 +2%
TRCT
3
Tower Research Capital (TRC)
New York
$590K 30,284 +2,076 +7%
Citadel Advisors
4
Citadel Advisors
Florida
$488K 25,054 +7,924 +46%
Jane Street
5
Jane Street
New York
$366K 18,823 +8,084 +75%
VF
6
Virtu Financial
New York
$292K 15,017 -12,975 -46%
HF
7
HRT Financial
New York
$220K 11,346 +11,346 New
Citigroup
8
Citigroup
New York
$28K 1,440 -100 -6%
Toronto Dominion Bank
9
Toronto Dominion Bank
Ontario, Canada
$27K 1,400
Simplex Trading
10
Simplex Trading
Illinois
$7K 360 -15,181 -98%
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
-49,014 Closed
UBS Group
12
UBS Group
Switzerland
-3,209 Closed